CoChat

Microencapsulation of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis subsp. lactis BB-12 in alginate and pectin, and the effects on bacterial acid and bile resistance

Open access
Mumcu, Ayla, Temiz, Ayhan, Denkbas, Emir Baki · 2026 · Biotech Studies

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; 9 of the 39 sources its claims cite were checked for support.

Abstract

This study aimed to encapsulate Lactobacillus acidophilus LA-5 (LA-5) and Bifidobacterium animalis subsp. lactis BB-12 (BB-12) in alginate and pectin, and to determine the effects of acid and bile resistance. The emulsion method was used; different gel and CaCl2 concentrations and stirring rate were studied comparatively for the characterization of microcapsules. Alginate microcapsules were smaller and exhibited agglomeration behavior, while pectin microcapsules were fairly homogeneous and had a smooth shape. Encapsulation efficiency (EE) percentages of the bacteria cells encapsulated with alginate and pectin varied within a very narrow range of 83 to 85%. The size of microcapsules increased as the gel concentration increased, and decreased as the CaCl2 concentration and stirring rate increased. Microencapsulated cells had more acid and bile resistance than free cells. No significant difference was found between alginate and pectin microcapsules of the two strains in terms of acid and bile resistance. The probiotic strains encapsulated with pectin and alginate maintained higher levels of viability under acid conditions at pH 2 and 3 than at pH 1 after 24 hours of incubation.

Overview

CoChat Summary

TL;DR

This study compared alginate and pectin microencapsulation of *Lactobacillus acidophilus* LA-5 and *Bifidobacterium animalis* subsp. *lactis* BB-12 using the emulsion method. Both carriers produced microcapsules with similar encapsulation efficiency and improved acid and bile resistance relative to free cells, with pectin forming more uniform capsules.

Key findings

  • Under the selected conditions, encapsulation efficiency ranged from 83% to 85% for both alginate and pectin microcapsules; Table 1 reports LA-5: 83.6 ± 0.6% (alginate) and 85.6 ± 0.4% (pectin), and BB-12: 84.6 ± 0.2% (alginate) and 83.6 ± 0.6% (pectin).
  • Microcapsule size increased with higher gel concentration and decreased with higher CaCl2 concentration and stirring speed; the optimal conditions were 1% alginate, 2% CaCl2, 2000 rpm and 2% pectin, 6% CaCl2, 2000 rpm.
  • Pectin microcapsules were described as fairly homogeneous and smooth, while alginate microcapsules were smaller and showed agglomeration.
  • Microencapsulation improved stress tolerance: free LA-5 and BB-12 “could not resist” pH 1 and showed no viable cells after 30 min, whereas microencapsulated cells retained viability longer; in 0.5% bile after 24 h, free cells were 4.1 log CFU/mL (LA-5) and 4.8 log CFU/mL (BB-12), versus 5.9/5.6 log CFU/mL for encapsulated LA-5 and 5.6/5.2 log CFU/mL for encapsulated BB-12 in alginate/pectin, respectively.

Methods

  • The study used the emulsion method to microencapsulate lyophilized LA-5 and BB-12 in sodium alginate and low-methoxyl pectin, varying polymer concentration, CaCl2 concentration, and stirring speed.
  • Microcapsules were characterized for morphology, size, agglomeration behavior, viable cell numbers, and encapsulation efficiency; microscopy included simple light microscopy and fluorescence microscopy with SYTO®9 staining.
  • Acid resistance was tested in 0.5% NaCl at pH 1, 2, and 3; bile resistance was tested in 0.5% bile solution, and viable counts were measured by pour plating. Experiments were done in triplicate (n = 3) and analyzed by one-way ANOVA with Tukey’s test at P < 0.05.

Limitations

  • The paper states that pectin-based microcapsules may require formulation optimization to overcome mechanical limitations and to obtain smaller size and higher EE%.
  • The results section states that “only the selected gel and CaCl2 concentrations and stirring speeds were proven” and that other conditions were varied one at a time; this limits broader inference across interacting process parameters.
  • Evident from the text: the work reports in vitro acid and bile tests only; it does not include an in vivo digestion, storage, or food-matrix performance study.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.38042/biotechstudies.1849883

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Simple light microscope images of alginate and pectin microcapsules with 4x objective: a-b; alginate microcapsules, c-d; pectin microcapsules.
Figure 1 Simple light microscope images of alginate and pectin microcapsules with 4x objective: a-b; alginate microcapsules, c-d; pectin microcapsules.From the PDF
Figure 2 Effect of carrier (alginate or pectin) concentration on microcapsule size. (Values are mean ± SD, n=3)
Figure 2 Effect of carrier (alginate or pectin) concentration on microcapsule size. (Values are mean ± SD, n=3)From the PDF
Figure 3 Effect of CaCl2 concentration on alginate and pectin microcapsule size. (Values are mean ± SD, n=3)
Figure 3 Effect of CaCl2 concentration on alginate and pectin microcapsule size. (Values are mean ± SD, n=3)From the PDF
Figure 4 Effect of stirring speed on alginate and pectin microcapsule size. (Values are mean ± SD, n=3)
Figure 4 Effect of stirring speed on alginate and pectin microcapsule size. (Values are mean ± SD, n=3)From the PDF
Figure 5 Fluorescence microscope images of alginate and pectin microcapsules with 20x objective: a) Microencapsulated LA-5 cells in alginate, b) Microencapsulated BB-12 cells in alginate, c) Microencapsulated LA-5 cells in pectin, d) Microencapsulated BB-12 cells in pectin.
Figure 5 Fluorescence microscope images of alginate and pectin microcapsules with 20x objective: a) Microencapsulated LA-5 cells in alginate, b) Microencapsulated BB-12 cells in alginate, c) Microencapsulated LA-5 cells in pectin, d) Microencapsulated BB-12 cells in pectin.From the PDF
Figure 6 Effect of alginate and pectin microencapsulation on the viability of LA-5 in pH 1. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).
Figure 6 Effect of alginate and pectin microencapsulation on the viability of LA-5 in pH 1. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).From the PDF
Figure 7 Effect of alginate and pectin microencapsulation on the viability of LA-5 in pH 2. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).
Figure 7 Effect of alginate and pectin microencapsulation on the viability of LA-5 in pH 2. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).From the PDF
Figure 8 Effect of alginate and pectin microencapsulation on the viability of LA-5 in pH 3. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).
Figure 8 Effect of alginate and pectin microencapsulation on the viability of LA-5 in pH 3. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).From the PDF
Figure 9 Effect of alginate and pectin microencapsulation on the viability of BB-12 in pH 1. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).
Figure 9 Effect of alginate and pectin microencapsulation on the viability of BB-12 in pH 1. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).From the PDF
Figure 10 Effect of alginate and pectin microencapsulation on the viability of BB-12 in pH 2. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).
Figure 10 Effect of alginate and pectin microencapsulation on the viability of BB-12 in pH 2. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).From the PDF
Figure 11 Effect of alginate and pectin microencapsulation on the viability of BB-12 in pH 3. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).
Figure 11 Effect of alginate and pectin microencapsulation on the viability of BB-12 in pH 3. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).From the PDF
Figure 12 Effect of alginate and pectin microencapsulation on the viability of LA-5 in 0.5% bile solution. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).
Figure 12 Effect of alginate and pectin microencapsulation on the viability of LA-5 in 0.5% bile solution. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).From the PDF
Figure 13 Effect of alginate and pectin microencapsulation on the viability of BB-12 in 0.5% bile solution. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).
Figure 13 Effect of alginate and pectin microencapsulation on the viability of BB-12 in 0.5% bile solution. Different uppercase letters represent significant differences among samples at the same incubation time ( P < 0.05); lowercase letters indicate the significant differences between the times of the same sample ( P < 0.05).From the PDF

Verification

Claims the paper makes

8 Valid · 1 Not valid · 11 Not checked · 59 Own results and interpretations

40 more claims

Create a free account to see all 79 claims and to verify the 4 references still open.

See all claims — free account
  • Probably not a substantial claim. 18
  • It may state two separate claims as one. 24
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 55 references

Research works printed but not linked: 2

  1. Mortazavian, A.M., Azizi, A., Ehsani, M.R., Razavi, S.H., Mousavi, S.M., Sohrabvandi, S., & Reinheimer, J.A. (2008). Survival of encapsulated probiotic bacteria in Iranian yogurt drink (Doogh) after the product exposure to simulated gastrointestinal conditions. Milchwissenschaft, 63(4):349-472.
  2. Mumcu, A.Ş., & Temiz, A. (2014). Effects of prebiotics on growth and acidifying activity of probiotic bacteria. Gıda, 39(2):71-77. https://doi.org/10.5505/gida.66375 · doi:10.5505/gida.66375

Metadata

Authors
Mumcu, A., Temiz, A., & Denkbas, E. B.
Affiliations
  • Olive Research Institute
  • HACETTEPE ÜNİVERSİTESİ, MÜHENDİSLİK FAKÜLTESİ, GIDA MÜHENDİSLİĞİ BÖLÜMÜ
  • BAŞKENT ÜNİVERSİTESİ, MÜHENDİSLİK FAKÜLTESİ, BİYOMEDİKAL MÜHENDİSLİĞİ BÖLÜMÜ, BİYOMEDİKAL MÜHENDİSLİĞİ PR. (ÜCRETLİ)
Corresponding author
Mumcu, Ayla
Venue
Biotech Studies
Published
2026-03-05
Issue
35
Pages
35-1849883
ISSN
2687-3761 (ISSN-L)
OpenAlex
W7118175869
Cited by
0
References
55
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Biotech Studies (publishedVersion)
  • DergiPark (Istanbul University) (submittedVersion)
Funders
Hacettepe Üniversitesi
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Microencapsulation and Drying Processes
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Proteins in Food Systems
Keywords
microencapsulation, Lactobacillus acidophilus LA-5, Bifidobacterium animalis subsp. lactis BB-12, alginate, pectin, probiotics, acid resistance, bile resistance, encapsulation efficiency, emulsion method, microcapsule size, bacterial viability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.